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Abstract
Background: Primary biliary cirrhosis (PBC) is a chronic liver disease characterized by intrahepatic bile-duct destruction,
cholestasis, and fibrosis. It can lead to cirrhosis and eventually liver failure. PBC also shows some regional differences with
respect to incidence and prevalence that are becoming more pronounced each year. Recently, researchers have paid more
attention to PBC. To evaluate the development of PBC research during the past 11 years, we determined the quantity and
quality of articles on this subject. We also compared the contributions of scientists from the US, UK, Japan, Italy, Germany,
and China.
Methods: The English-language papers covering PBC published in journals from 2000 through 2010 were retrieved from the
PubMed database. We recorded the number of papers published each year, analyzed the publication type, and calculated
the accumulated, average impact factors (IFs) and citations from every country. The quantity and quality of articles on PBC
were compared by country. We also contrasted the level of PBC research in China and other countries.
Results: The total number of articles did not significantly increase during the past 11 years. The number of articles from the
US exceeded those from any other country; the publications from the US also had the highest IFs and the most citations.
Four other countries showed complex trends with respect to the quantity and quality of articles about PBC.
Conclusion: The researchers from the US have contributed the most to the development of PBC research. They currently
represent the highest level of research. Some high-level studies, such as RCTs, meta-analyses, and in-depth basic studies
should be launched. The gap between China and the advanced level is still enormous. Chinese investigators still have a long
way to go.
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Introduction
Background
Primary biliary cirrhosis (PBC) is an immune-mediated chronic
liver disease characterized by intrahepatic bile-duct destruction,
cholestasis, and fibrosis. It can lead to cirrhosis and eventually liver
failure [1]. The disease primarily affects women over 40 years of
age (female preponderance (9–10:1), although younger patients
have been diagnosed, including children [2]. According to
reported data, a latitudinal geo-epidemiological pattern has been
proposed to describe development of PBC [3]. The disease is most
common in northern Europe and North America, especially in
Scandinavia, Great Britain, and the Northern Midwest region of
the US. It is rarest in Australia. It has been suggested that the
incidence of PBC is increasing over time. For example, in
Sheffield, UK, the rates rose from 5.8 to 20.5 cases per million
between 1980 to 1999 [4,5]. Antimitochondrial antibodies in the
serum are a hallmark of PBC. Ursodeoxycholic acid (UDCA) is
currently the only FDA-approved medical treatment for PBC.
Liver transplantation is performed in patients with advanced or
late-stage PBC. However, the limited number of donors has
narrowed the application of liver transplantation, it has also posed
large economic burdens on patients and government.
With the growing incidence of PBC and other emerging issues,
the scientific communities of different countries have gradually
attached more importance to this condition. Researchers attempt
to understand the pathogenesis of PBC and to develop new
diagnostic methods and remedies. However, the trends in the
annual numbers of scientific publications and in the quality of
research performed in different countries are not immediately
clear. We analyzed English-language papers on PBC published in
international journals over the past 11 years (2000.1.1–
2010.12.31) and investigated the quantity and quality of articles
from different regions.
Methods
In this retrospective study, we evaluated all articles related to
PBC indexed in PubMed over the past 11 years. Our search Mesh
term was ‘‘liver cirrhosis, biliary,’’ and searched within a specific
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(English only). The information within all selected articles was
drawn out independently by two investigators (BD Qin and
Y Liang), who surveyed the titles, authors, abstracts, publication
types, and other details. Discrepancies were resolved by review of
the full text. The research output from different countries was
determined using the first author’s institutional affiliations. Impact
factors (IFs) from 2000 to 2010 were determined using Thomson
Reuters in ISI’s Journal Citation Reports (JCR) [6]. In addition,
the number of citations of every article was calculated using the
Web of Science of ISI Database.
First, the total annual number of articles and externally funded
publications related to PBC were calculated. Second, the
publication types of the articles were analyzed. These included
basic research, clinical research, case reports, reviews, commen-
taries, and other types of articles. Third, the accumulated and
average IFs, and citations of every article were calculated to permit
comparison of the quality of the publications, which were mainly
from the top five countries, ranked by the total number of articles
produced during the past 11 years (See Flowchart S1).
Statistical analyses
Statistical analyses were performed using SPSS 18.0 software
(IBM, New York, US), and statistical results are given in Tables
and Figures. Results mostly show the trends and scientific
contributions of different countries. The differences of contribu-
tions (including quantity and quality) to PBC by different regions
were detected using the Kruskal-Wallis test, and the means were
compared using one-factor ANOVA. The trends with respect to
number of articles were analyzed via curvilinear regression. P
values of less than 0.05 were considered significant. These were
determined using two-tailed tests.
Results
Total number of articles
From 2000 to 2010, a total of 1819 articles were published in
the 389 journals indexed in PubMed. They were mainly from
52 countries. The number of articles published was largest in 2010
(205/1819) and least in 2009 (133/1819). However, the trend in
annual number of articles published around the world fluctuated
slightly and the number increased insignificantly from 2000 to
2010 (R
2=0.023, P=0.656). The number of externally funded
articles exhibited the same trend as the total number of articles
(R
2=0.234, P=0.131) (Fig. 1). The top five countries by number
of articles were the US (22.9%, 417/1819), Japan (18.5%, 335/
1819), UK (11.4%, 208/1819), Italy (8.0%, 145/1819), and
Germany (5.4%, 99/1819). China (3.5%, 63/1819), including
mainland China (35), Hong Kong (4), and Taiwan (24), ranked the
seventh among the 52 countries. The growth in the annual
number of published articles from these countries changed
insignificantly, with the exception of China (R
2=0.732,
P=0.001) (Fig. 2).
Publication types
The number of published clinical studies was the largest,
followed by basic studies, case reports, commentaries, and reviews
(Fig. 3). Of all the 427 clinical studies, case-control studies
occupied overwhelming share (66.98%), to which the authors from
Japan, the US, and the UK made the main contributions.
Japanese researchers published the most case reports, while US
researchers conducted the most clinical trials (Fig. 4). However,
there were only 38 RCTs in all 1819 articles. These were
published by researchers from 11 countries. Although the number
of RCTs was minor, there were still significant differences among
the six countries (P,0.05), and the quantity of RCTs from the
USA was found to be greater than those of other countries even
though there were only 13 articles.
Impact factors
In accordance to the JCR, the 325 journals that published
articles about PBC were indexed in SCI and had impact factors
from 2000 to 2010, but 64 journals containing 91 articles had no
impact factors. After excluding these 91 articles, we determined
the impact factors of each one in its year of publication. Then we
calculated the accumulated and average IFs of these countries.
The annual total IFs from the US was significantly higher than
those of other countries (P,0.05), and the four other countries
showed complex trends and differed significantly despite the
insignificant difference between the UK and Japan
(P=0.622)(Fig. 5). In addition, the average IFs were similar to
above-mentioned results shown in Table 1, and the average IFs
differed significantly among the six countries (P,0.05).
Citations
In the ISI database, we found the number of citations for every
article and analyzed the total number of citations and the average
citation rate from the top 5 countries and China. The results are
shown in Figure 6. The US had 417 articles and 8334 citations.
The UK had 208 articles and 3763citations, Japan had 335
articles and 3156 citations. Italy had 146 articles and 1558
citations. Germany had 99 articles and 1194 citations. China had
63 articles and 395 citations. These differences among these six
countries were found to be significant (P,0.05). Papers from the
US and UK had the greatest average number of citations (19.99
and 18.09), followed by Germany, Italy, and Japan (12.06, 10.67,
and 9.45) (Fig. 7). Chinese papers had the fewer citations on
average than papers from the above 5 countries.
Favorite and most high-impact medical journals
The most popular journals are listed in Table 2. Hepatology was
the No. 1 journal with respect to number of articles about PBC,
followed by J Hepatol, Am J Gastroenterol and Liver Int. Hepatology also
appeared among the top four journals of the five countries. A total
of 416 articles from 2000 to 2010 were published in the top five
ranking sub-specialty medical journals, which included Hepatology,
Gastroenterology, Gut, J Hepatol, and Am J Gastroenterol. Only 19
articles on PBC were published in the four leading general-
medicine journals: NEJM, Lancet, JAMA, and BMJ. There were
only 3 articles published in the top three basic medical journals
(Nature: 2 articles, Science: 1 article, Cell: 0 articles).
Discussion
This is, to our knowledge, the first study to analyze the
distribution of English-language papers on PBC from 2000 to
2010, and it is also the first report to evaluate the quantity and
quality of the top five countries as ranked by number of articles.
The present study shows that the total number of articles about
PBC has not varied drastically. Although that number reached the
peak in 2010, the rate of increase is not considerable. The trend in
the annual number of articles has not shown any evident increase,
probably because the studies on PBC have reached a bottleneck or
found some kind of limiting factor. In addition, a total of 575
articles (31.6%) on PBC were found to have been externally
funded, and the quality of funded studies was much higher with
respect to both average IFs and number of citations (P,0.05). This
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doi:10.1371/journal.pone.0035366.g001
Figure 2. Trends in annual numbers of articles written by researchers from the six countries from 2000 to 2010.
doi:10.1371/journal.pone.0035366.g002
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into PBC research.
Clinical studies made up a considerable proportion of the
articles evaluated, but highly convincing RCTs were rare. Only 17
meta-analyses were published during the past 11 years, and they
mainly evaluated the effects of therapy rather than risk factors,
diagnostic criteria, or prevention. Although basic studies made up
the second largest subgroup, only 3 of these articles were published
in the top three journals. Therefore, the scientific levels of these
basic studies are probably not high and need to be improved. Case
Figure 3. Total number of basic research, case reports, clinical research, commentaries, and reviews relating to PBC worldwide from
2000 to 2010.
doi:10.1371/journal.pone.0035366.g003
Figure 4. Number of clinical trials, RCTs, and case reports written by authors from the six countries between 2000 and 2010.
doi:10.1371/journal.pone.0035366.g004
The Review of Scientific Publications on PBC
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35366reports mainly discussed specific symptoms and complications.
Japanese researchers contributed the most case reports (28.2%).
Researchers should consider summarizing and classifying these
findings.
These five developed countries, the US, UK, Japan, Italy, and
Germany, have been in the forefront of global scientific research
for many years, and authors from these countries have contributed
the most to PBC with respect to both quantity and quality of
published articles. The US clearly leads other countries in research
productivity (accounting for 22.9% of the total), with an annual
number of articles exceeding any of the other countries in the past
11 years, except in 2000, 2001, and 2006. Japan followed the US,
but the annual number of papers from Japan has shown
a downward trend, reaching its lowest point in 2009. None of
the three other countries surpassed the US or Japan in number of
articles except in 2004. The ranking with respect to number of
articles was the UK, Italy, and Germany in the third, fourth, and
fifth places. In addition to the number of articles, US researchers
have also written the papers of the highest quality (P,0.05), with
the highest annual total and average IFs. There were no significant
differences in annual total IFs between Japan and the UK, but the
average IFs of articles from Japan were significantly lower than
those from the UK (P,0.05). Italians have published more top-
quality articles than Germans with respect to both annual total
and average IFs. In addition to these five countries, Canada and
France also showed advanced-level PBC research. Researchers
from these two countries contributed 4 articles in NEJM (France: 3
articles, Canada: 1 article) during the past 11 years.
Citations are another indicator of publication quality, showing
the degree to which the paper has been accepted by other authors
in the same field. Articles from the US exceeded those of all other
countries with respect to average number of citations (P,0.05)
during the past 11 years, and the cumulative number of citations is
also fairly high. The UK surpassed Japan with respect to total
number of citations in 2003, which was similar to the relationship
between Germany and Italy. In 2010, the ranking with respect to
total number of citations was US, UK, Japan, Italy, and Germany.
In the present study, Hepatology (163 articles) was found to be the
most popular journal (8.9%) for authors writing about PBC. It
printed 71 articles from the US, most of which were written by the
researchers from the University of California at Davis School of
Medicine (Gershwin ME). This laboratory represents the most
advanced level of PBC research, where the researchers make
Figure 5. Annual total IFs of articles published by researchers from the top five countries and China from 2000 to 2010.
doi:10.1371/journal.pone.0035366.g005
Table 1. Average impact factors (IF) of articles written by
authors from six countries from 2000 to 2010, based on the
annual IFs of the journals published.
Year USA UK Canada Germany Italy China
2000 4.576 4.907 2.204 3.688 4.484 1.586
2001 3.627 4.347 1.745 4.093 2.334 2.497
2002 4.457 4.727 5.173 3.704 1.180 0
2003 7.940 1.928 2.444 2.573 1.822 2.424
2004 3.042 3.398 4.249 1.934 2.426 0
2005 2.765 2.718 3.306 2.394 3.432 2.166
2006 5.567 6.463 5.991 5.717 3.771 1.795
2007 3.120 3.584 2.890 3.250 4.394 2.314
2008 5.139 3.830 3.983 4.385 3.006 3.480
2009 4.550 4.065 2.836 3.496 4.500 3.863
2010 5.134 4.120 5.625 5.106 4.966 2.899
Total 4.515 4.046 3.972 3.787 3.560 2.681
doi:10.1371/journal.pone.0035366.t001
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base. A total of 416 articles were published in the five highest-
impact hepatology and gastroenterology journals, three of which
are the top three popular journals with respect to total number of
PBC articles. However, Gut and Gastroenterology published fewer
articles (41 articles in Gut, 46 articles in Gastroenterology). For the
four leading medical journals, only 19 articles were (NEJM:1 1
articles, Lancet: 6 articles, JAMA: 1article, BMJ: 1article). It can be
seen from the above results that the number of PBC articles
published in top journals is still relatively low.
Although China is ranked No. 7 with respect to total number of
articles on PBC during the past 11 years, the number has shown
Figure 6. Annual citations of articles related to PBC written by authors from the top five countries and China from 2000 to 2010.
doi:10.1371/journal.pone.0035366.g006
Figure 7. Average number of citations in articles published by researchers from the different countries during the past 11 years.
doi:10.1371/journal.pone.0035366.g007
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2=0.732, P=0.001). The total
number of citations of publications from China are still below the
internationally advanced level, such as that observed in the five
countries discussed in present study. However, the annual total IFs
of articles has also increased each year, reaching a peak in 2007.
The average IFs from China (3.651) surpassed Japan (2.971) and
Germany (3.532), but it not to a statistically significant extent
(P=0.514 and P=0.908). From the analysis of publication types,
none of the RCT articles were written by researchers from China.
With the increases in the number of PBC patients, Chinese
researchers should launch more multicenter prospective studies
and RCTs aimed at risk factors, diagnosis, complications,
treatments, and prevention. In conclusion, the contribution of
China to PBC research is less than that of the top five countries.
Therefore, there is a lot of room for Chinese researchers to
improve.
Actually, there may be some limitations in the literature. First,
the six countries selected may not represent the status of all articles
and may also not be representative of the international level of
PBC research. However, these countries have produced 70% of
the total number of English-language articles published during the
past 11 years, which suggests that research in these countries is
advanced. Second, we only retrieved English-language documents
and passed over articles published in other languages. Although
English is the international language of communication in
academic fields and high-quality articles and journals are mainly
published in English, there are still 290 (13.7%) articles related to
PBC indexed in the PubMed database published in non-English
languages during the past 11 years. These include 37 French
papers, 48 German papers, 46 Japanese papers, 58 Chinese
papers, 30 Spanish papers, 8 Italian papers and more. This may
have affected the efficacy and accuracy of the current assessment
of the development of PBC research around the world because
some researchers may release articles on PBC in their own
languages rather than in English. Third, it may not be appropriate
or accurate to assess the quality of these articles using IFs [7].
There are many inherent limitations to IFs as quantitative
measurement tools. Only when citations are uniformly spread
between articles can we use IFs to objectively evaluate the quality
of individual articles. However, the non-parametric distribution of
citations to articles lies at the heart of the problem with impact
factors. Some journals include many useful articles, accounting for
most of the total number of citations of journals [8]. Moreover,
document type can affect IF. Review papers attract more citations
than original research papers [9]. Original research papers,
however, are the main engines that generate new knowledge,
and so are the best representatives of research levels. In the present
study, increases in the IFs of articles related to PBC may
paradoxically reduce the overall influence of said research on
the scientific community because fewer original research papers
will be published. For the reasons given above, other metrics that
assess the quality and quantity of citations have been proposed,
such as the Eigenfactor Score and Article Influence Score, which
must be taken into account when attempting to determine impact
factor [10]. However, Bollen et al. found that scientific impact is
a multi-dimensional characteristic that cannot be adequately
captured by one metric [11]. Any single indicator may not
accurately indicate the quality and impact of articles or academic
journals. Despite its many at present unavoidable limitations, the
journal impact factor is still the most commonly used indicator of
the quality or at least the popularity of a given scientific journal.
In conclusion, the present study provides some useful in-
formation regarding scientific studies of primary biliary cirrhosis.
US researchers have contributed the most to the development of
PBC studies, and the country currently produces the highest level
of PBC research. More RCTs, meta-analyses, and high-level basic
studies should be carried out. Although the quantity and quality of
articles written by Chinese scientists have increased every year, the
gap between China and the advanced level in PBC research is still
enormous.
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